BridgePort Financial Solutions’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281K Buy
7,647
+383
+5% +$18.1K 0.08% 185
2025
Q4
$370K Buy
7,264
+580
+9% +$29.7K 0.1% 156
2025
Q3
$371K Sell
6,684
-4,899
-42% -$287K 0.1% 156
2025
Q2
$799K Buy
11,583
+5,488
+90% +$373K 0.27% 77
2025
Q1
$423K Buy
6,095
+37
+0.6% +$3.06K 0.19% 104
2024
Q4
$540K Buy
+6,058
New +$655K 0.24% 87

Other funds holding NVO

BridgePort Financial Solutions's NVO Position: Q1 2026 in Review

BridgePort Financial Solutions increased its Novo Nordisk (NVO) stake by 5.3% in Q1 2026, buying an estimated $18.1K and bringing the position to 7,647 shares worth $281K. The position accounts for 0.08% of the portfolio, ranked #185.

BridgePort Financial Solutions first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $799K in Q2 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • BridgePort Financial Solutions held 7,647 shares of Novo Nordisk worth $281K as of Q1 2026.
  • BridgePort Financial Solutions bought 383 Novo Nordisk shares in Q1 2026, an estimated $18.1K.
  • Novo Nordisk made up 0.08% of BridgePort Financial Solutions's portfolio in Q1 2026, its #185 holding.
  • BridgePort Financial Solutions first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • BridgePort Financial Solutions's Novo Nordisk position peaked at $799K in Q2 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on BridgePort Financial Solutions's 13F filing for Q1 2026, filed 16 Apr 2026.